Sotac Pharmaceuticals

Sotac Pharmaceuticals FCF-margin

Fri likviditetsstrøm-margin for Sotac Pharmaceuticals (SOTAC.NS) pr. 22. okt. 2026 er -22,01 %. I foregående år var Fri likviditetsstrøm-margin -32,66 % — en ændring på -32,61 % (højere).

FCF-margin

-22,01 %

YoY

-32,61%

Senest opdateret:

Fri likviditetsstrøm-margin for Sotac Pharmaceuticals er 2025 -22,01 % . Fri likviditetsstrøm-margin for Sotac Pharmaceuticals var 2024 -32,66 % . Det falder dermed med -32,61% højere sammenlignet med året før.

Sotac Pharmaceuticals FCF-margin historik

  • 3 år

  • 10 år

  • 25 år

  • Maks

FCF-margin
Dato
FCF-margin
1. jan. 2020
-34,07 INR
1. jan. 2021
-7,10 INR
1. jan. 2022
3,89 INR
1. jan. 2023
2,58 INR
1. jan. 2024
-32,66 INR
1. jan. 2025
-22,01 INR
Sotac Pharmaceuticals FCF-margin historik
ÅRFCF-marginYoY
-22,01 %-32,61%
-32,66 %-1.366,87%
2,58 %-33,74%
3,89 %-154,80%
-7,10 %-79,16%
-34,07 %—

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Sotac Pharmaceuticals Aktieanalyse

Hvad laver Sotac Pharmaceuticals? Sotac Pharmaceuticals Ltd develops and manufactures pharmaceutical products under loan license or contract manufacturing agreements for various marketers. The company specializes in Non Beta-Lactam tablets, capsules, syrup, and external preparations, with a therapeutic portfolio covering Anti-Diabetic, Anti-Psychotic, Vitamins, Minerals, Iron, Anti-Cold, Anti-Allergic, Derma Products, Antacid, Anti-Ulcerants, PPI, Anti-Emetics, Cardiac, Anti-Hypertensives, Analgesic, Anti-Pyretic, Anti-Inflammatory, Anti-Bacterial, Anti-Viral, General Antibiotics IP-Lactams and Non-IP-Lactams, Anti-Fungal, and Cephalosporin products. Its subsidiaries SOTAC Healthcare, SOTAC Research, and SOTAC Lifescience support its manufacturing and development activities. The company generates revenue by producing pharmaceutical products on a contract manufacturing basis for different marketers, who then market and sell these products under their own brands. Sotac Pharmaceuticals' manufacturing services are utilized by various marketers seeking to outsource production without maintaining their own facilities. The firm's focus on a diverse therapeutic portfolio ensures consistent demand across multiple healthcare segments. Sotac Pharmaceuticals' manufacturing capabilities are tailored to meet the specific requirements of its marketer clients, offering both Non Beta-Lactam and Beta-Lactam product lines. The company's subsidiaries provide additional support in healthcare, research, and lifescience sectors, enhancing its overall service offerings. Its product range spans from basic medications like Anti-Cold and Anti-Allergic to specialized treatments such as Anti-Fungal and Cephalosporin antibiotics. Sotac Pharmaceuticals er et af de mest populære virksomheder på Eulerpool.com.

Hyppigt stillede spørgsmål om Sotac Pharmaceuticals aktie

Fri likviditetsstrøm-margin for Sotac Pharmaceuticals er -22,01 % i 2025.

Fri likviditetsstrøm-margin for Sotac Pharmaceuticals ændrede sig fra -32,66 % til -22,01 %, hvilket repræsenterer en ændring på -32,61 %. Værdien er højere end i foregående år.

På Eulerpool kan du finde den fuldstændige historiske udvikling af Fri likviditetsstrøm-margin Sotac Pharmaceuticals siden 2006 – med årlige værdier, diagrammer og detaljeret analyse.

FCF-marginen måler procentdelen af omsætningen, der konverteres til fri likviditetsstrøm. Den indikerer, hvor effektivt en virksomhed genererer kontanter fra sin drift.

En 'god' varierer efter branche og virksomhedens udviklingsstadium. På Eulerpool kan du sammenligne Fri likviditetsstrøm-margins Sotac Pharmaceuticals med konkurrenter og branchegjennemsnittet for at afgøre, om den er attraktiv.

For at evaluere Fri likviditetsstrøm-margins er det afgørende at sammenligne det med andre virksomheder i samme branche og sektor. På Eulerpool kan du finde branchsammenligninger for Fri likviditetsstrøm-margin.

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Marginer — Sotac Pharmaceuticals

Alle nøgletal — Sotac Pharmaceuticals